Recombinant human albumin for biomanufacturing and formulations
CreaCyte® rHSA by InVitria is designed to give your biomanufacturing and formulation processes the reliability you need. This high-purity recombinant human serum albumin is produced in the USA using a non-mammalian expression system. It offers a chemically defined alternative to albumin from animal sources, helping you minimize variability and achieve more consistent results in drug development and cell culture.
Albumin plays a vital role in biological systems - regulating osmotic pressure, serum pH, and oxidation, while transporting ions, fatty acids, toxins, and small-molecule drugs. Because of these functions, albumin directly influences cell viability and growth, making its quality and consistency essential for your bioprocess performance.
While bovine serum sources such as fetal bovine serum (FBS) have long been used for laboratory grade albumin, they can introduce variability and undefined components that challenge modern, highly sensitive biopharmaceutical workflows. As processes become more complex, they require albumin with higher specificity, tighter control, and reduced risk of contaminants.
Through our partnership with InVitria, Evonik provides access to a portfolio of recombinant human albumin products that meet these stringent requirements. With CreaCyte® rHSA, you can rely on consistent quality that supports smoother scale-up, more robust cell culture performance, and greater confidence across your development and manufacturing activities.
Drive performance in biopharma manufacturing with high-purity solutions
CreaCyte® rHSA includes a range of recombinant human serum albumins designed to meet the diverse needs of biopharmaceutical manufacturing.
Choose the formulation that best aligns with your application:
| Product | InVitria brand | Description | Download |
|---|---|---|---|
| CreaCyte® rHSA for cell culture media | Cellastim® S | Lipid-enhanced formulation for excellent cell growth and productivity | Download flyer |
| CreaCyte® rHSA as excipient | Exbumin® | Improved stability in vaccines, cell and gene therapies, and protein formulations | Download flyer |
| CreaCyte® rHSA for biomanufacturing | Optibumin® | 20% and 25% liquid solutions for seamless integration into biopharma workflows | Download flyer |
The benefits of CreaCyte® rHSA at a glance
Scalable ‒ produced in a non-mammalian, recombinant expression system
Reliable ‒ highly pure albumin produced in the USA
Reproducible and safe ‒ chemically defined and non-animal derived
Seamless integration into your bioprocess
Versatile formulations and packaging options
Consistent quality ‒ manufactured according to cGMP at an ISO9001 certified facility
Elimination of prion and viral risk ‒ naturally free of prion agents, minimal risk of contamination
Want to learn more about CreaCyte® rHSA by InVitria?
Please note: Evonik acts solely as a distributor of the products manufactured by InVitria and has no responsibility or involvement in the quality assurance, quality control, testing, or release of the products as well as product safety and regulatory compliance.
ANY QUESTIONS? JUST CONTACT US.
"If you are looking for ways to more efficient bioprocessing and improved performance, our innovative cell culture solutions will be of great value to you. Contact us to find out how we can support and meet your needs."
Dr. Kristina Klinker
Business Development Manager